Risk Factors for Muscle Loss During Neoadjuvant Therapy for Esophageal Cancer. Shimizu D, Miyata K, Fukaya M, Sugita S, et al. Anticancer Res 2023;43:1309-1315.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shimizu D, Miyata K, Fukaya M, Sugita S, et al. Risk Factors for Muscle Loss During Neoadjuvant Therapy for Esophageal Cancer. Anticancer Res 2023;43:1309-1315.
PMID: 36854507